# Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working

> **NCT06980493** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Sohag University** · enrollment: 30 (estimated)

## Conditions studied

- Tinea Capitis

## Interventions

- **DRUG:** Amphotericine in liposome (Ambisome®)

## Key facts

- **NCT ID:** NCT06980493
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06980493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06980493, "Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06980493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*